PROVENTUS HEALTH SOLUTIONS LLC
MARCO ISLAND, FLORIDA

Vice President & Chief Marketing Officer, Oncology Global Marketing, Eli Lilly and Company Leadership role for oncology marketing at Lilly and ImClone. Responsible for Global Brand and lifecycle management for 6 major oncology brands; New Products Planning for over 20 assets in areas of immuno-oncology, cell cycle, microenvironment and cytotoxic therapies; Market Research and Forecasting for all oncology products and all geographies; Pricing, Reimbursement, and Access for all oncology products and all geographies; Business Development valuations and due diligence for external opportunities; and setting overall marketing direction and customer experience for oncology along with developing systems and competencies to achieve desired customer experience goals and product sales. Executive Director, Oncology Global Marketing, Eli Lilly and Company Key role in identification, acquisition, and integration of ImClone Systems Inc into Lilly. Participated in the creation of business units within Lilly; led the effort to create combined commercial organization across US, EU and Japan; and established governance and operating structure for oncology commercial efforts. Evaluation and due diligence of potential business development opportunities. Director, Oncology Global Marketing, Eli Lilly and Company Leadership role in global brand management and lifecycle management for 2 major brands - GEMZAR and ALIMTA, new product planning, oncology franchise brand, and development of affiliate marketing capabilities. Director, Clinical Operations - Oncology, Eli Lilly and Company Manager, Oncology Global Market Research, Eli Lilly and Company Manager, GEMZAR Global Marketing, Eli Lilly and Company Manager, Oncology New Product Planning, Eli Lilly and Company District Sales Manager, Eli Lilly and Company Market Research Analyst- PROZAC, Eli Lilly and Company Medical Information Specialist, Eli Lilly and Company Hospital Sales Representative, Eli Lilly and Company Retail Sales Representative, Eli Lilly and Company